Temesta 1mg
Temesta 1mg is a medicine authorised by Swissmedic under authorisation number 36203. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 September 1973 and the authorisation is valid without a time limit. ATC code N05BA06 places the medicine in the group Psycholeptics.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Temesta 1mg, Tabletten | B | 18 September 1973 |
| 2 | Temesta 2.5mg, Tabletten | B | 18 September 1973 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 13 | 20 | Tablette(n) | N05BA06 | 01.04.1. | B |
| 21 | 50 | Tablette(n) | N05BA06 | 01.04.1. | B |
| 56 | 20 | Tablette(n) | N05BA06 | 01.04.1. | B |
| 64 | 50 | Tablette(n) | N05BA06 | 01.04.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Temesta 1mg authorised in Switzerland?
Yes. Temesta 1mg is authorised by Swissmedic under authorisation number 36203, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Temesta 1mg have?
Temesta 1mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Temesta 1mg?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.